findmyKOL
Clinical trialNCT02417467CompletedPhase 3Interventional

Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial

SponsorMcGill UniversityEnrollment376Smoking Cessation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Mark J Eisenberg, MD MPH

    McGill University, Jewish General Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Mazankowski Alberta Heart Institute

    Edmonton, Alberta, Canada

  • St. Boniface Hospital

    Winnipeg, Manitoba, Canada

  • Allen Greenspoon Medicine Profesionnal Corporation

    Hamilton, Ontario, Canada

  • Baran Medicine Professional Corporation

    Kingston, Ontario, Canada

  • Institut de Recherche de L'Hôpital Montfort

    Ottawa, Ontario, Canada

  • Ottawa Hospital

    Ottawa, Ontario, Canada

  • the Bridge Engagement Centre

    Ottawa, Ontario, Canada

  • Canadian Centre for Clinical Trials

    Thornhill, Ontario, Canada

  • Michael Garron Hospital

    Toronto, Ontario, Canada

  • Toronto General Hospital

    Toronto, Ontario, Canada

  • Hôpital Cité-de-la-Santé

    Laval, Quebec, Canada

  • Centre Hospitalier de L'Université de Montréal (chum)

    Montreal, Quebec, Canada

  • Jewish General Hospital

    Montreal, Quebec, Canada

  • Montreal General Hospital

    Montreal, Quebec, Canada

  • Institut de Cardiologie Et de Pneumologie de Québec (iucpq)

    Québec, Quebec, Canada

  • Centre de Recherche Sur Le Vieillissement

    Sherbrooke, Quebec, Canada

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2016
Primary completion
31 Dec 2019
Completion
1 Oct 2020
Last update posted
28 Jan 2021
Registered enrollment
376
Registry id
NCT02417467

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.